Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-049255

President and CEO sold 3,479 shares at an average $5.23 ($18,196)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-09-08 Sale : show line 1 in the form −16 $5.26 $84 626,461 D
2022-09-08 Sale : show line 2 in the form −3,463 $5.23 $18,111 622,998 D
Open-market sales · 3,479 sh · avg $5.23 · $18,196
Loading xslF345X03/doc4.xml…